Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 21 |
NetGPI | no | yes: 0, no: 21 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 22 |
GO:0043226 | organelle | 2 | 22 |
GO:0043227 | membrane-bounded organelle | 3 | 22 |
GO:0043229 | intracellular organelle | 3 | 22 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 22 |
GO:0110165 | cellular anatomical entity | 1 | 22 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: E9AM18
Term | Name | Level | Count |
---|---|---|---|
GO:0006355 | regulation of DNA-templated transcription | 6 | 2 |
GO:0009889 | regulation of biosynthetic process | 4 | 2 |
GO:0010468 | regulation of gene expression | 5 | 2 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 2 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 2 |
GO:0019222 | regulation of metabolic process | 3 | 2 |
GO:0031323 | regulation of cellular metabolic process | 4 | 2 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 2 |
GO:0050789 | regulation of biological process | 2 | 2 |
GO:0050794 | regulation of cellular process | 3 | 2 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 2 |
GO:0051252 | regulation of RNA metabolic process | 5 | 2 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0080090 | regulation of primary metabolic process | 4 | 2 |
GO:1903506 | regulation of nucleic acid-templated transcription | 7 | 2 |
GO:2001141 | regulation of RNA biosynthetic process | 6 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003700 | DNA-binding transcription factor activity | 2 | 22 |
GO:0005488 | binding | 1 | 22 |
GO:0008270 | zinc ion binding | 6 | 22 |
GO:0043167 | ion binding | 2 | 22 |
GO:0043169 | cation binding | 3 | 22 |
GO:0046872 | metal ion binding | 4 | 22 |
GO:0046914 | transition metal ion binding | 5 | 22 |
GO:0140110 | transcription regulator activity | 1 | 22 |
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0016874 | ligase activity | 2 | 1 |
GO:0000976 | transcription cis-regulatory region binding | 5 | 2 |
GO:0000977 | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 6 | 2 |
GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | 3 | 2 |
GO:0001067 | transcription regulatory region nucleic acid binding | 4 | 2 |
GO:0003677 | DNA binding | 4 | 2 |
GO:0003690 | double-stranded DNA binding | 5 | 2 |
GO:0043565 | sequence-specific DNA binding | 5 | 2 |
GO:1990837 | sequence-specific double-stranded DNA binding | 6 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 124 | 126 | PF00675 | 0.428 |
CLV_NRD_NRD_1 | 219 | 221 | PF00675 | 0.447 |
CLV_NRD_NRD_1 | 397 | 399 | PF00675 | 0.448 |
CLV_NRD_NRD_1 | 424 | 426 | PF00675 | 0.555 |
CLV_NRD_NRD_1 | 458 | 460 | PF00675 | 0.409 |
CLV_NRD_NRD_1 | 532 | 534 | PF00675 | 0.514 |
CLV_PCSK_FUR_1 | 217 | 221 | PF00082 | 0.499 |
CLV_PCSK_KEX2_1 | 124 | 126 | PF00082 | 0.409 |
CLV_PCSK_KEX2_1 | 219 | 221 | PF00082 | 0.473 |
CLV_PCSK_KEX2_1 | 263 | 265 | PF00082 | 0.550 |
CLV_PCSK_KEX2_1 | 397 | 399 | PF00082 | 0.377 |
CLV_PCSK_KEX2_1 | 571 | 573 | PF00082 | 0.711 |
CLV_PCSK_PC1ET2_1 | 263 | 265 | PF00082 | 0.550 |
CLV_PCSK_PC1ET2_1 | 571 | 573 | PF00082 | 0.507 |
CLV_PCSK_SKI1_1 | 103 | 107 | PF00082 | 0.529 |
CLV_PCSK_SKI1_1 | 397 | 401 | PF00082 | 0.549 |
DOC_CKS1_1 | 284 | 289 | PF01111 | 0.490 |
DOC_PP2B_LxvP_1 | 320 | 323 | PF13499 | 0.545 |
DOC_PP4_FxxP_1 | 45 | 48 | PF00568 | 0.436 |
DOC_PP4_FxxP_1 | 520 | 523 | PF00568 | 0.538 |
DOC_PP4_FxxP_1 | 80 | 83 | PF00568 | 0.368 |
DOC_USP7_MATH_1 | 237 | 241 | PF00917 | 0.702 |
DOC_USP7_MATH_1 | 247 | 251 | PF00917 | 0.594 |
DOC_USP7_MATH_1 | 310 | 314 | PF00917 | 0.453 |
DOC_USP7_MATH_1 | 350 | 354 | PF00917 | 0.467 |
DOC_USP7_MATH_1 | 380 | 384 | PF00917 | 0.523 |
DOC_WW_Pin1_4 | 1 | 6 | PF00397 | 0.659 |
DOC_WW_Pin1_4 | 283 | 288 | PF00397 | 0.471 |
DOC_WW_Pin1_4 | 333 | 338 | PF00397 | 0.533 |
LIG_14-3-3_CanoR_1 | 134 | 138 | PF00244 | 0.560 |
LIG_14-3-3_CanoR_1 | 304 | 312 | PF00244 | 0.434 |
LIG_14-3-3_CanoR_1 | 354 | 359 | PF00244 | 0.480 |
LIG_14-3-3_CanoR_1 | 457 | 463 | PF00244 | 0.402 |
LIG_14-3-3_CanoR_1 | 63 | 71 | PF00244 | 0.649 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.660 |
LIG_BRCT_BRCA1_1 | 516 | 520 | PF00533 | 0.359 |
LIG_FHA_1 | 201 | 207 | PF00498 | 0.615 |
LIG_FHA_1 | 315 | 321 | PF00498 | 0.499 |
LIG_FHA_1 | 342 | 348 | PF00498 | 0.413 |
LIG_FHA_1 | 379 | 385 | PF00498 | 0.385 |
LIG_FHA_1 | 6 | 12 | PF00498 | 0.488 |
LIG_FHA_1 | 66 | 72 | PF00498 | 0.625 |
LIG_FHA_2 | 329 | 335 | PF00498 | 0.568 |
LIG_FHA_2 | 411 | 417 | PF00498 | 0.506 |
LIG_FHA_2 | 459 | 465 | PF00498 | 0.417 |
LIG_FHA_2 | 563 | 569 | PF00498 | 0.620 |
LIG_LIR_Apic_2 | 281 | 287 | PF02991 | 0.605 |
LIG_LIR_Apic_2 | 461 | 465 | PF02991 | 0.392 |
LIG_LIR_Apic_2 | 517 | 523 | PF02991 | 0.266 |
LIG_LIR_Gen_1 | 450 | 455 | PF02991 | 0.427 |
LIG_LIR_Gen_1 | 87 | 96 | PF02991 | 0.315 |
LIG_LIR_Nem_3 | 39 | 45 | PF02991 | 0.413 |
LIG_LIR_Nem_3 | 450 | 454 | PF02991 | 0.404 |
LIG_LIR_Nem_3 | 562 | 566 | PF02991 | 0.534 |
LIG_Rb_LxCxE_1 | 178 | 196 | PF01857 | 0.225 |
LIG_Rb_LxCxE_1 | 21 | 39 | PF01857 | 0.269 |
LIG_SH2_CRK | 284 | 288 | PF00017 | 0.427 |
LIG_SH2_STAP1 | 20 | 24 | PF00017 | 0.393 |
LIG_SH2_STAP1 | 451 | 455 | PF00017 | 0.446 |
LIG_SH2_STAT5 | 100 | 103 | PF00017 | 0.387 |
LIG_SH2_STAT5 | 211 | 214 | PF00017 | 0.490 |
LIG_SH2_STAT5 | 364 | 367 | PF00017 | 0.419 |
LIG_SH2_STAT5 | 455 | 458 | PF00017 | 0.458 |
LIG_SH3_2 | 129 | 134 | PF14604 | 0.445 |
LIG_SH3_2 | 337 | 342 | PF14604 | 0.560 |
LIG_SH3_3 | 126 | 132 | PF00018 | 0.466 |
LIG_SH3_3 | 334 | 340 | PF00018 | 0.481 |
LIG_SH3_3 | 342 | 348 | PF00018 | 0.416 |
LIG_SH3_3 | 353 | 359 | PF00018 | 0.308 |
LIG_SH3_3 | 383 | 389 | PF00018 | 0.546 |
LIG_SH3_3 | 460 | 466 | PF00018 | 0.405 |
LIG_SH3_3 | 487 | 493 | PF00018 | 0.481 |
LIG_SUMO_SIM_par_1 | 202 | 208 | PF11976 | 0.535 |
LIG_TYR_ITIM | 449 | 454 | PF00017 | 0.499 |
MOD_CDK_SPxK_1 | 283 | 289 | PF00069 | 0.482 |
MOD_CK1_1 | 562 | 568 | PF00069 | 0.449 |
MOD_CK2_1 | 365 | 371 | PF00069 | 0.542 |
MOD_CK2_1 | 410 | 416 | PF00069 | 0.515 |
MOD_CK2_1 | 84 | 90 | PF00069 | 0.310 |
MOD_Cter_Amidation | 531 | 534 | PF01082 | 0.429 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.576 |
MOD_GlcNHglycan | 238 | 242 | PF01048 | 0.679 |
MOD_GlcNHglycan | 251 | 254 | PF01048 | 0.573 |
MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.545 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.603 |
MOD_GSK3_1 | 160 | 167 | PF00069 | 0.414 |
MOD_GSK3_1 | 200 | 207 | PF00069 | 0.469 |
MOD_GSK3_1 | 310 | 317 | PF00069 | 0.442 |
MOD_GSK3_1 | 350 | 357 | PF00069 | 0.518 |
MOD_GSK3_1 | 380 | 387 | PF00069 | 0.604 |
MOD_GSK3_1 | 510 | 517 | PF00069 | 0.393 |
MOD_N-GLC_1 | 175 | 180 | PF02516 | 0.357 |
MOD_NEK2_1 | 510 | 515 | PF00069 | 0.458 |
MOD_NEK2_1 | 65 | 70 | PF00069 | 0.643 |
MOD_NEK2_1 | 84 | 89 | PF00069 | 0.437 |
MOD_NEK2_2 | 166 | 171 | PF00069 | 0.441 |
MOD_NEK2_2 | 212 | 217 | PF00069 | 0.572 |
MOD_NEK2_2 | 328 | 333 | PF00069 | 0.453 |
MOD_OFUCOSY | 307 | 314 | PF10250 | 0.418 |
MOD_OFUCOSY | 351 | 358 | PF10250 | 0.506 |
MOD_OFUCOSY | 396 | 402 | PF10250 | 0.409 |
MOD_OFUCOSY | 412 | 419 | PF10250 | 0.420 |
MOD_OFUCOSY | 438 | 443 | PF10250 | 0.299 |
MOD_OFUCOSY | 524 | 531 | PF10250 | 0.383 |
MOD_PIKK_1 | 53 | 59 | PF00454 | 0.488 |
MOD_PKA_2 | 133 | 139 | PF00069 | 0.445 |
MOD_PKA_2 | 303 | 309 | PF00069 | 0.418 |
MOD_PKA_2 | 405 | 411 | PF00069 | 0.467 |
MOD_PKA_2 | 458 | 464 | PF00069 | 0.398 |
MOD_PKA_2 | 65 | 71 | PF00069 | 0.578 |
MOD_Plk_1 | 415 | 421 | PF00069 | 0.478 |
MOD_Plk_4 | 133 | 139 | PF00069 | 0.352 |
MOD_Plk_4 | 200 | 206 | PF00069 | 0.398 |
MOD_Plk_4 | 458 | 464 | PF00069 | 0.560 |
MOD_ProDKin_1 | 1 | 7 | PF00069 | 0.645 |
MOD_ProDKin_1 | 283 | 289 | PF00069 | 0.472 |
MOD_ProDKin_1 | 333 | 339 | PF00069 | 0.407 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.434 |
TRG_ENDOCYTIC_2 | 42 | 45 | PF00928 | 0.377 |
TRG_ENDOCYTIC_2 | 451 | 454 | PF00928 | 0.413 |
TRG_ER_diArg_1 | 216 | 219 | PF00400 | 0.480 |
TRG_ER_diArg_1 | 397 | 399 | PF00400 | 0.377 |
TRG_Pf-PMV_PEXEL_1 | 363 | 367 | PF00026 | 0.266 |
TRG_Pf-PMV_PEXEL_1 | 9 | 13 | PF00026 | 0.400 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HTT0 | Leptomonas seymouri | 35% | 75% |
A0A0N1I9N1 | Leptomonas seymouri | 73% | 100% |
A0A0S4INQ1 | Bodo saltans | 48% | 96% |
A0A1X0NUI9 | Trypanosomatidae | 38% | 72% |
A0A1X0NZM6 | Trypanosomatidae | 54% | 100% |
A0A3R7M581 | Trypanosoma rangeli | 54% | 100% |
A0A3R7MD54 | Trypanosoma rangeli | 36% | 70% |
A0A3S5H7A4 | Leishmania donovani | 35% | 75% |
A0A3S7X2B6 | Leishmania donovani | 95% | 100% |
A4HC58 | Leishmania braziliensis | 36% | 100% |
A4HH68 | Leishmania braziliensis | 86% | 100% |
A4I4B2 | Leishmania infantum | 95% | 100% |
C9ZKS5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
C9ZSC0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 72% |
E9ADR2 | Leishmania major | 95% | 100% |
E9AGY6 | Leishmania infantum | 35% | 75% |
E9AVJ1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 75% |
Q4QBY8 | Leishmania major | 36% | 100% |
V5BFS7 | Trypanosoma cruzi | 38% | 71% |
V5BUH3 | Trypanosoma cruzi | 51% | 100% |